The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control
Primary Purpose
Prediabetes, Newly Diagnosed Type 2 Diabetes
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
jerusalem artichoke and fermented soybeans powder mixture
placebo
Sponsored by
About this trial
This is an interventional treatment trial for Prediabetes
Eligibility Criteria
Inclusion Criteria:
1. All subjects were with prediabetes (IFG or IGT) or newly diagnosed type 2 DM (T2DM) no taking medicine. IFG was defined as fasting glucose between 100 and 125 mg/dL and IGT was defined as 2-h OGTTs glucose levels 140-199 mg/dL. Newly diagnosed type 2 diabetes was defined as fasting glucose ≥126 mg/dL or 2-h OGTTs level ≥ 200 mg/dL.
Exclusion Criteria:
- glucose lowering medications or insulin injections;
- abnormal liver or renal function;
- chronic stomach and intestines disease;
- chronic alcoholism;
- pregnancy or intending to become pregnant during time of study.
- complications;
- an occupation that could be dangerous if hypoglycemia should occur.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Placebo Comparator
Arm Label
Test group
Placebo group
Arm Description
jerusalem artichoke and fermented soybeans powder mixture supplementation
placebo supplementation
Outcomes
Primary Outcome Measures
Blood glucose level by 2-h oral glucose tolerance tests (OGTTs)
Secondary Outcome Measures
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02506582
Brief Title
The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control
Official Title
The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control
Study Type
Interventional
2. Study Status
Record Verification Date
July 2015
Overall Recruitment Status
Completed
Study Start Date
June 2013 (undefined)
Primary Completion Date
December 2014 (Actual)
Study Completion Date
January 2015 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yonsei University
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The purpose of this randomized, double-blind, placebo-controlled study was to determine whether jerusalem artichoke and fermented soybeans powder mixture is effective in the control of blood glucose level in subjects with prediabetes or newly diagnosed type 2 diabetes.
Detailed Description
The objective of this clinical study was to evaluate the effect of jerusalem artichoke and fermented soybean powder mixture supplementation on blood glucose. A randomized, double-blinded, placebo-controlled study was conducted on 60 subjects with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or newly diagnosed type 2 diabetes. The subjects were randomly assigned to either a group ingesting 40 g jerusalem artichoke and fermented soybean powder mixture supplementation daily or a placebo group for 12-week. We assessed fasting and postprandial levels of glucose.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Prediabetes, Newly Diagnosed Type 2 Diabetes
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
60 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Test group
Arm Type
Experimental
Arm Description
jerusalem artichoke and fermented soybeans powder mixture supplementation
Arm Title
Placebo group
Arm Type
Placebo Comparator
Arm Description
placebo supplementation
Intervention Type
Dietary Supplement
Intervention Name(s)
jerusalem artichoke and fermented soybeans powder mixture
Intervention Description
40 g jerusalem artichoke and fermented soybean powder mixture
Intervention Type
Dietary Supplement
Intervention Name(s)
placebo
Intervention Description
40 g powdered rice flour
Primary Outcome Measure Information:
Title
Blood glucose level by 2-h oral glucose tolerance tests (OGTTs)
Time Frame
12 week
10. Eligibility
Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
1. All subjects were with prediabetes (IFG or IGT) or newly diagnosed type 2 DM (T2DM) no taking medicine. IFG was defined as fasting glucose between 100 and 125 mg/dL and IGT was defined as 2-h OGTTs glucose levels 140-199 mg/dL. Newly diagnosed type 2 diabetes was defined as fasting glucose ≥126 mg/dL or 2-h OGTTs level ≥ 200 mg/dL.
Exclusion Criteria:
glucose lowering medications or insulin injections;
abnormal liver or renal function;
chronic stomach and intestines disease;
chronic alcoholism;
pregnancy or intending to become pregnant during time of study.
complications;
an occupation that could be dangerous if hypoglycemia should occur.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jong Ho Lee, PhD
Organizational Affiliation
Yonsei University
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Glucose Control
We'll reach out to this number within 24 hrs